Noymi Yam
11Patents
5h-index
20Co-inventors
66Inventor score
Filing activity: Nov 1, 1999 → Aug 25, 2020
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6368626B1 | Controlled delivery of active agents | Human Necessities | 53 | Expired |
| US6630165B2 | Methods for providing effective reboxetine therapy with once-a-day dosing | Human Necessities | 18 | Expired |
| US6855334B2 | Controlled delivery of active agents | Human Necessities | 10 | Expired |
| US10391108B2 | Pharmaceutical tetracycline composition for dermatological use | Emerging Cross-Sectional Technologies | 6 | Active |
| US6387403B1 | Dosage forms and methods for providing effective reboxetine therapy with once-a-day dosing | Human Necessities | 5 | Expired |
| US9918998B2 | Pharmaceutical tetracycline composition for dermatological use | Emerging Cross-Sectional Technologies | 2 | Active |
| US6706282B1 | Controlled delivery of phenoxyethyl-substituted 1,2,4-triazolones | Human Necessities | 1 | Expired |
| US10786470B2 | Formulations for administration of eflornithine | Chemistry; Metallurgy | 1 | Active |
| US11439612B2 | Formulations for administration of eflornithine | Chemistry; Metallurgy | 0 | Active |
| US10881672B2 | Pharmaceutical tetracycline composition for dermatological use | Emerging Cross-Sectional Technologies | 0 | Active |
| US8524749B2 | Controlled release compositions of tizanidine | Human Necessities | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.